Biomarin Argentina S.R.L. (Argentina)

BioMarin Pharmaceutical Inc is a biotechnology company. The company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, with a focus on rare genetic conditions. BioMarin has developed eight important medicines for patients with significant unmet medical needs, treating conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. The company utilizes multiple treatment modalities, including biologics, gene therapy, oligonucleotides, and small molecules, to pursue the greatest transformative potential for each condition. BioMarin's cardiovascular program is focused on developing new and transformative treatment options for people with cardiovascular conditions, leveraging the company's deep genetic knowledge to increase understanding of the biology underlying disease. BioMarin Pharmaceutical Inc. continues to advance therapies for rare genetic conditions and is extending its base to apply its scientific expertise to the treatment of more common genetic disorders.